Spironolactone Tablet
Product Images NDC 71335-2301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of spironolactone showing its steroidal core with lactone and thioester functional groups.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival probability curve comparing Spironolactone and placebo groups over 48 months. The y-axis shows probability from 0 to 1, and the x-axis shows time in months. The curve for Spironolactone (n=822) declines more slowly than placebo (n=841), indicating higher survival probability, with a log-rank p-value of less than 0.001.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot displaying hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone and placebo. The subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use, with corresponding sample sizes (N). The plot visually compares efficacy between spironolactone and placebo across these groups.*
FDA Label Image

Label (Lbl713352301)

Label (Lbl713352301)
Label for Spironolactone Tablets USP 25 mg oral tablets. The label indicates the product contains 1000 tablets, repackaged by Bryant Ranch Prepack, Inc., and manufactured by Frontida BioPharm, Inc. It includes storage instructions and warnings to keep out of reach of children. The tablet is debossed with 'MP 35'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.